Case-control study of environmental risk factors for Parkinson's disease in Belgium

European Journal of Epidemiology

Volumn 18, Issue 12, 2003, Pages 1133-1142

  Pals, Philippe ^a,b   Van Everbroeck, Bart ^a   Grubben, Bart ^b   Viaene, Maria Kristina ^c   Dom, René ^d   Van Der Linden, Chris ^e   Santens, Patrick ^f   Martin, Jean Jacques ^a   Cras, Patrick ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c Neurotoxicology Section   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e Department of Neurology   (United States)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Comorbidity; Diet; Gender; Organophosphates; Pesticides; Smoking

Indexed keywords

TOLUENE; ZINC;

ADULT; AGED; ARTICLE; BELGIUM; CASE CONTROL STUDY; CONFIDENCE INTERVAL; ENVIRONMENTAL FACTOR; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; METALLURGY; NULLIPARA; ONSET AGE; PARKINSON DISEASE; PREVALENCE; PROSTATECTOMY; QUESTIONNAIRE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; BELGIUM; CASE-CONTROL STUDIES; DEMOGRAPHY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0347635521     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:EJEP.0000006639.05690.92     Document Type: Article

References (39)

1. Gibb WR. Functional neuropathology in Parkinson's disease. Eur Neurol 1997; 2: 21-25.
2. Mizuno Y, Yoshino H, Ikebe S, et al. Mitochondrial dysfunction in Parkinson's disease. Ann Neurol 1998; 44(3 Suppl 1): S99-S109.
3. Parker WD Jr., Swerdlow RH. Mitochondrial dysfunction in idiopathic Parkinson disease. Am J Hum Genet 1998; 62(4): 758-762.
4. Schapira AH. Mitochondrial dysfunction in neurodegenerative disorders. Biochim Biophys Acta 1998; 1366(1-2): 225-233.
5. Riess O, Kruger R. Parkinson's disease - a multifactorial neurodegenerative disorder. J Neural Transm Suppl 1999; 56: 113-125.
6. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983; 219(4587): 979-980.
7. Barbeau A. Etiology of Parkinson's disease: A research strategy. Can J Neurol Sci 1984; 11: 24-28.
8. Langston JW. Epidemiology versus genetics in Parkinson's disease: Progress in resolving an age-old debate. Ann Neurol 1998; 44(3 Suppl 1): S45-S52.
9. Koller W, Vetere Overfield B, Gray C, et al. Environmental risk factors in Parkinson's disease. Neurology 1990; 40(8): 1218-1221.
10. Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Richardson RJ. The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living. Neurology 1998; 50(5): 1346-1350.
11. Tanner CM, Chen B, Wang WZ, et al. Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci 1987; 14(3 Suppl): 419-423.
12. Scheider WL, Hershey LA, Vena JE, Holmlund T, Marshall JR, Freudenheim. Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease. Mov Disord 1997; 12(2): 190-196.
13. de Rijk MC, Breteler MM, den Brceijen JH, et al. Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol 1997; 54(6): 762-765.
14. Golbe LI, Cody RA, Duvoisin RC. Smoking and Parkinson's disease. Search for a dose-response relationship. Arch Neurol 1986; 43(8): 774-778.
15. Gorell JM, Rybicki BA, Johnson CC, Peterson EL. Smoking and Parkinson's disease: A dose-response relationship. Neurology 1999; 52(1): 115-119.
16. Ben Shlomo Y. The epidemiology of Parkinson's disease. Baillieres Clin Neurol 1997; 6(1): 55-68.
17. Seidler A, Hellenbrand W, Robra BP, et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: A case-control study in Germany. Neurology 1996; 46(5): 1275-1284.
18. de Rijk MC, Breteler MM, Graveland GA, et al. Prevalence of Parkinson's disease in the elderly: The Rotterdam Study. Neurology 1995; 45(12): 2143-2146.
19. Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology 1997; 48(3): 650-658.
20. Gorell JM, Johnson CC, Rybicki BA, et al. Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease. Neurotoxicology 1999; 20(2-3): 239-247.
21. Gorell JM, Rybicki BA, Johnson CC, Peterson EL. Occupational metal exposures and the risk of Parkinson's disease. Neuroepidemiology 1999; 18(6): 303-308.
22. Rybicki BA, Johnson CC, Uman J, Gorell JM. Parkinson's disease mortality and the industrial use of heavy metals in Michigan. Mov Disord 1993; 8(1); 87-92.
23. Pal PK, Samii A, Calne DB. Manganese neurotoxicity: A review of clinical features, imaging and pathology. Neurotoxicology 1999; 20(2-3): 227-238.
24. Hirsch EC, Faucheux BA. Iron metabolism and Parkinson's disease. Mov Disord 1998; 1: 39-45.
25. Paik SR, Shin HJ, Lee JH, Chang CS, Kim J. Copper(II)-induced self-oligomerization of alpha-synuclein. Biochem J 1999; 3: 821-828.
26. Munch G, Gerlach M, Sian J, Wong A, Riederer P. Advanced glycation end products in neurodegeneration: More than early markers of oxidative stress? Ann Neurol 1998; 44(3 Suppl 1): S85-S88.
27. Uitti RJ, Snow BJ, Shinotoh H, et al. Parkinsonism induced by solvent abuse. Ann Neurol 1994; 35(5): 616-619.
28. Voog L, Eriksson T. Toluene-induced decrease in rat plasma concentrations of tyrosine and tryptophan. Acta Pharmacol Toxicol Copenh 1984; 54(2): 151-153.
29. Juorio AV, Yu PH. Effects of benzene and other organic solvents on the decarboxylation of some brain aromatic-L-amino acids. Biochem Pharmacol 1985; 34(9): 1381-1387.
30. Benignus VA. Health effects of toluene: A review. Neurotoxicology 1981; 2(3): 567-588.
31. Ritz B, Yu F. Parkinson's disease mortality and pesticide exposure in California 1984-1994. Int J Epidemiol 2000; 29(2): 323-329.
32. Le Couteur DG, McLean AJ, Taylor MC, Woodham BL, Board PG. Pesticides and Parkinson's disease. Biomed Pharmacother 1999; 53(3): 122-130.
33. Bhatt MH, Elias MA, Mankodi AK. Acute and reversible parkinsonism due to organophosphate pesticide intoxication: Five cases. Neurology 1999; 52(7): 1467-1471.
34. Schwartz GG. Multiple sclerosis and prostate cancer: What do their similar geographies suggest? Neuroepidemiology 1992; 11(4-6): 244-254,
35. Bhatt M, Desai J, Mankodi A, Elias M, Wadia N. Posttraumatic akinetic-rigid syndrome resembling Parkinson's disease: A report on three patients. Mov Disord 2000; 15(2): 313-317.
36. Sawada H, Shimohama S. Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci Biobehav Rev 2000; 24(1): 143-147.
37. Disshon KA, Dluzen DE. Estrogen reduces acute striatal dopamine responses in vivo to the neurotoxin MPP+ in female, but not male rats. Brain Res 2000; 868(1): 95-104.
38. Sawada H, Ibi M, Kihara T, Urushitani M, Akaike A, Shimohama S. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J Neurosci Res 1998; 54(5): 707-719,
39. Tsang KL, Ho SL, Lo SK. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology 2000; 54(12): 2292-2298.